Page last updated: 2024-10-21

menthol and Acute Pain

menthol has been researched along with Acute Pain in 2 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Acute Pain: Intensely discomforting, distressful, or agonizing sensation associated with trauma or disease, with well-defined location, character, and timing.

Research Excerpts

ExcerptRelevanceReference
"The mean migraine duration was 18."3.11A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. ( Arkuszewski, M; Ecochard, L; Kim, BK; Li, Z; Lian, Y; Su, W; Wan, Q; Wang, H; Wang, SJ; Wen, S; Yin, F; Yu, S; Yu, T; Zhou, J, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yu, S3
Kim, BK3
Wang, H3
Zhou, J3
Wan, Q3
Yu, T3
Lian, Y3
Arkuszewski, M3
Ecochard, L3
Wen, S3
Yin, F3
Li, Z3
Su, W3
Wang, SJ3
Liu, B1
Fan, L1
Balakrishna, S1
Sui, A1
Morris, JB1
Jordt, SE1

Trials

1 trial available for menthol and Acute Pain

ArticleYear
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022

Other Studies

1 other study available for menthol and Acute Pain

ArticleYear
TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain.
    Pain, 2013, Volume: 154, Issue:10

    Topics: Acute Pain; Analgesia; Animals; Cells, Cultured; Inflammation; Male; Menthol; Mice; Mice, Inbred C57

2013